These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31929843)

  • 1. Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice.
    Wang Y; Zhu S; Liu H; Wei W; Tu Y; Chen C; Song J; Li J; Sun S; Wang C; Xu Z
    Dis Markers; 2019; 2019():7420196. PubMed ID: 31929843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of LKB1/AMPK/mTOR metabolic axis response to global ischaemia in brain, heart, liver and kidney in a rat model of cardiac arrest.
    Majd S; Power JHT; Chataway TK; Grantham HJM
    BMC Cell Biol; 2018 Jun; 19(1):7. PubMed ID: 29921218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin downregulates autophagy to promote apoptosis-induced dilated cardiomyopathy via regulating the AMPK/mTOR pathway.
    Zhang S; Wei X; Zhang H; Wu Y; Jing J; Huang R; Zhou T; Hu J; Wu Y; Li Y; You Z
    Biomed Pharmacother; 2023 Jun; 162():114691. PubMed ID: 37060659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1.
    Sakamoto K; Zarrinpashneh E; Budas GR; Pouleur AC; Dutta A; Prescott AR; Vanoverschelde JL; Ashworth A; Jovanović A; Alessi DR; Bertrand L
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E780-8. PubMed ID: 16332922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
    Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
    Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
    Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
    J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
    Jia Y; Zuo D; Li Z; Liu H; Dai Z; Cai J; Pang L; Wu Y
    Chem Pharm Bull (Tokyo); 2014; 62(1):45-53. PubMed ID: 24390491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTRP9 knockout exaggerates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy through inhibiting the LKB1/AMPK pathway.
    Zuo A; Zhao X; Li T; Li J; Lei S; Chen J; Xu D; Song C; Liu T; Li C; Guo Y
    J Cell Mol Med; 2020 Feb; 24(4):2635-2647. PubMed ID: 31930700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice.
    Ye J; Huang Y; Que B; Chang C; Liu W; Hu H; Liu L; Shi Y; Wang Y; Wang M; Zeng T; Zhen W; Xu Y; Shi L; Liu J; Jiang H; Ye D; Lin Y; Wan J; Ji Q
    EBioMedicine; 2018 Sep; 35():29-39. PubMed ID: 30228093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway.
    Yao Y; Xu X; Zhang G; Zhang Y; Qian W; Rui T
    Basic Res Cardiol; 2012 May; 107(3):267. PubMed ID: 22527657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
    Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
    Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
    Bian Y; Sun M; Silver M; Ho KK; Marchionni MA; Caggiano AO; Stone JR; Amende I; Hampton TG; Morgan JP; Yan X
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H1974-83. PubMed ID: 19801490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR remains unchanged in diet-resistant (DR) rats despite impaired LKB1/AMPK cascade in adipose tissue.
    Han J; Liang H; Tian D; Du J; Wang Q; Xi P; Wang H; Li Y
    Biochem Biophys Res Commun; 2016 Aug; 476(4):333-339. PubMed ID: 27235551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine-Monophosphate-Activated Protein Kinase Alpha/Mammalian Target of Rapamycin Axis in Mice.
    Wang YS; Du L; Liang X; Meng P; Bi L; Wang YL; Wang C; Tang B
    Hepatology; 2019 Apr; 69(4):1614-1631. PubMed ID: 30552782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway.
    Wang S; Wang Y; Zhang Z; Liu Q; Gu J
    Cell Death Dis; 2017 Aug; 8(8):e3018. PubMed ID: 28837153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway.
    Hsu JL; Liu SP; Lee CC; Hsu LC; Ho YF; Huang HS; Guh JH
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Oct; 387(10):979-90. PubMed ID: 25005758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of LKB1 in the heart leads to energy deprivation and impaired cardiac function.
    Jessen N; Koh HJ; Folmes CD; Wagg C; Fujii N; Løfgren B; Wolf CM; Berul CI; Hirshman MF; Lopaschuk GD; Goodyear LJ
    Biochim Biophys Acta; 2010; 1802(7-8):593-600. PubMed ID: 20441792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen inhalation enhances autophagy via the AMPK/mTOR pathway, thereby attenuating doxorubicin-induced cardiac injury.
    Ma T; Yang L; Zhang B; Lv X; Gong F; Yang W
    Int Immunopharmacol; 2023 Jun; 119():110071. PubMed ID: 37080067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction.
    Ikeda Y; Sato K; Pimentel DR; Sam F; Shaw RJ; Dyck JR; Walsh K
    J Biol Chem; 2009 Dec; 284(51):35839-49. PubMed ID: 19828446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.